Business / Finance

RSS

Tecan's Phase Separator™: advancing automation for liquid biopsy and biobanking

Tecan proudly unveils Phase Separator™, an innovative liquid separation technology that promises to save time and improve accuracy in laboratory workflows. With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics, proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders.

From Tecan 21 Jul 2023

Arrayjet announces collaboration with Chemspace to augment its small molecule microarray services for drug discovery

Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that it has partnered with Chemspace, the largest online catalogue of small molecules and biologics, to augment and streamline the Company’s small molecule microarray (SMM) service offering.

From Arrayjet Ltd 19 Jul 2023

Bedfont® Boosts Cancer Research Fundraising Efforts with £200 Donation

Local Med-tech company, Bedfont® Scientific Ltd., is proudly donating £200 to support the noble fundraising efforts of its employees, the Bedfont® Family, who ran the Pretty Muddy 5K Obstacle Course on Saturday 1st July 2023, for Cancer Research UK.

From Bedfont® Scientific Ltd 18 Jul 2023

MGI Empowers Life Sciences Industry with Revolutionary What If Campaign at XXIIIrd International Congress of Genetics

MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the launch of a global brand campaign titled “What If?” at the XXIII International Congress of Genetics (ICG), a five-yearly conference to bring together the international genetics community from around the world.

From MGI 17 Jul 2023

PhoreMost appoints Professor Peter Parker and Dr Jason Imbriglio to Scientific Advisory Board

PhoreMost Ltd. announced Professor Peter Parker and Dr Jason Imbriglio as members of its Scientific Advisory Board (SAB).

From PhoreMost 17 Jul 2023

Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership

Evotec SE today announced that Bristol Myers Squibb Company has exercised its option to enter into an exclusive global licence agreement.

From Evotec 13 Jul 2023

Vernal Biosciences Announces Partnership With REPROCELL

Vernal Biosciences, a leader in mRNA and LNP manufacturing, and REPROCELL Inc., Japan’s first induced pluripotent stem cell (iPSC) company, have partnered to provide mRNA services in Japan at scale for research and clinical applications.

From REPROCELL 11 Jul 2023

Metrion Biosciences expands senior leadership team with appointments of Dr Robert Kirby as COO and Dr Edward Stevens as CSO

Metrion Biosciences Limited (“Metrion”), is a specialist ion channel contract research and drug discovery company.

From Metrion Biosciences Limited 6 Jul 2023

Camena Bioscience closes $10m Series A financing as demand for DNA synthesis technology increases

Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries.

From Camena Bioscience 3 Jul 2023

ATCC announces new award from BARDA to further support its medical countermeasures clinical studies network

ATCC will serve as a centralized facility to support the storage and distribution of clinical samples and investigational products for BARDA.

From American Type Culture Collection (ATCC) 29 Jun 2023

Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult

Albumedix Ltd., an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.

From Albumedix Ltd. 29 Jun 2023

Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine

Albumedix Ltd., a recognized global leader in Recombinant Human Albumin (rHA), specializing in the enablement of advanced therapies and biopharmaceuticals, today announces the expansion of its existing collaboration with Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.

From Albumedix Ltd. 29 Jun 2023

Researcher from Wageningen University wins Green CellDrop Giveaway

DeNovix Inc. is pleased to announce the winner of the Green CellDrop Automated Cell Counter Giveaway: Michiel Schrijen from Wageningen University, Netherlands! Selected at random from thousands of entries from scientists worldwide, the CellDrop will be housed in the Biosystematics Group at the university.

From DeNovix Inc. 29 Jun 2023

Mastering repeatability in cell culture with INTEGRA Biosciences’ WELLJET peristaltic pump dispenser

INTEGRA Biosciences’ WELLJET reagent dispenser and EasySnap™ dispensing cassettes offer a unique solution to common issues in cell-based workflows.

From INTEGRA Biosciences 27 Jun 2023

Berlin's senator for economic affairs, Franziska Giffey, and state secretary Michael Biel visit lab-tech company KNAUER

The management of KNAUER Wissenschaftliche Geräte GmbH, a well-known Berlin-based manufacturer of high-tech laboratory instruments.

From KNAUER Wissenschaftliche Geräte GmbH 26 Jun 2023

FUJIFILM Irvine Scientific offers expanded capabilities of Presagen’s Life Whisperer Platform to aid with clinical decision-making in IVF

Genetics AI-based software module added to provide objective scoring of embryo genetic integrity and likelihood of clinical pregnancy.

From FUJIFILM Irvine Scientific 24 Jun 2023

Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates

A new robotics platform was inaugurated at the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) on Thursday, June 15, 2023, in the presence of Thuringia's State Secretary for Research, Innovation and Economic Development.

From Analytik Jena AG 23 Jun 2023